Title :

Inhibitors of HOXA9 leukemogenic transcription factor are efficient on human AML cell models but not on normal human bone marrow CD34+ hematopoietic cells.

Author(s) :

Lambert, M. [Auteur]
Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Depauw, S. [Auteur]
Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Jambon, S. [Auteur]
Nhili, R. [Auteur]
Bellart, M. [Auteur]
Lutchmee, L. [Auteur]
Louis-Thérèse, L. [Auteur]
Boykin, D.W. [Auteur]
David-Cordonnier, M.-H [Auteur]
Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]

Conference title :

24th Congress of the European Hematology Association (EHA)

City :

Amsterdam (NETHERLANDS)

Country :

Pays-Bas

Start date of the conference :

2019

HAL domain(s) :

Sciences du Vivant [q-bio]

Language :

Anglais

Peer reviewed article :

Oui

Audience :

Internationale

Popular science :

Non

Collections :

• Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER) - UMR 9020 - UMR 1277

Source :

Harvested from HAL